申请人:MERCK PATENT GmbH
公开号:EP0755934A1
公开(公告)日:1997-01-29
Novel compounds of the formula I
in which
-Y-Z-, R1,R2,R3,R4,R5 and X have the meaning indicated in Patent Claim 1, and their salts
show endothelin receptor-antagonistic properties.
式 I 的新型化合物
其中
-Y-Z-、R1,R2,R3,R4,R5 和 X 具有专利权利要求 1 中所示的含义,以及它们的盐类
具有内皮素受体拮抗特性。